Brite Therapeutics
PrivateCompany Overview
Brite Therapeutics operates in Healthcare & Life Sciences and is based in Delaware.
Brite Therapeutics is a biotechnology company that develops novel treatments for obesity and related metabolic disorders by targeting brown and brite fat cell biology and advancing drug combinations.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brite Therapeutics Comparables
Compare Brite Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Energesis Pharmaceuticals, Inc. | 85% | |
| Eolo Pharma | 83% | |
| Adipo Therapeutics | 79% |
For institutional investors. Book with your work email.
Brite Therapeutics Funding Rounds
Historical fundraising activity
Brite Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Brite Therapeutics's valuation, stock price, and market status.
Is Brite Therapeutics a public or private company?
Brite Therapeutics is a private company.
What is the current stock price of Brite Therapeutics?
Brite Therapeutics is a private company, so its shares have no public market price. Caplight tracks Brite Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Brite Therapeutics worth (valuation)?
Valuation information for Brite Therapeutics is not publicly available.
Can I buy Brite Therapeutics stock?
Brite Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Brite Therapeutics's last funding round?
Funding round information for Brite Therapeutics is not publicly available.
Who are the main investors in Brite Therapeutics?
Investor information for Brite Therapeutics is not publicly disclosed.
Will Brite Therapeutics IPO soon?
No public IPO plans have been announced for Brite Therapeutics.
How can I track Brite Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Brite Therapeutics's shares on secondary markets.